Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L C Hofbauer

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 26, 2006
Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patientsH Dobnig, L C Hofbauer, V Viereck, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2001
Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone statusP Szulc, L C Hofbauer, A E Heufelder, et al.
Der Internist|June 17, 2016
[Diagnostics in osteology]F Jakob, F Genest, L Seefried, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 9, 2003
In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factorM Middeke, S Hoffmann, I Hassan, et al.
Bone|July 15, 2014
Outcome of glucose homeostasis in patients with glucocorticoid-induced osteoporosis undergoing treatment with bone active-drugsG Mazziotti, F Maffezzoni, M Doga, et al.
Biochemical and Biophysical Research Communications|October 24, 1998
Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokinesL C Hofbauer, C R Dunstan, T C Spelsberg, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 5, 2013
The non-interventional BonViva Intravenous Versus Alendronate (VIVA) study: real-world adherence and persistence to medication, efficacy, and safety, in patients with postmenopausal osteoporosisP Hadji, D Felsenberg, M Amling, et al.
Cell Death & Disease|February 26, 2016
p38 MAPK regulates the Wnt inhibitor Dickkopf-1 in osteotropic prostate cancer cellsA J Browne, A Göbel, S Thiele, et al.
The Journal of Clinical Endocrinology and Metabolism|May 14, 2011
Cortical bone status is associated with serum osteoprotegerin concentration in men: the STRAMBO studyP Szulc, G Hawa, S Boutroy, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1997
Soluble interleukin-1 receptor antagonist serum levels in smokers and nonsmokers with Graves' ophthalmopathy undergoing orbital radiotherapyL C Hofbauer, T Mühlberg, A König, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 26, 2006
Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patientsH Dobnig, L C Hofbauer, V Viereck, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2001
Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone statusP Szulc, L C Hofbauer, A E Heufelder, et al.
Der Internist|June 17, 2016
[Diagnostics in osteology]F Jakob, F Genest, L Seefried, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 9, 2003
In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factorM Middeke, S Hoffmann, I Hassan, et al.
Bone|July 15, 2014
Outcome of glucose homeostasis in patients with glucocorticoid-induced osteoporosis undergoing treatment with bone active-drugsG Mazziotti, F Maffezzoni, M Doga, et al.
Biochemical and Biophysical Research Communications|October 24, 1998
Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokinesL C Hofbauer, C R Dunstan, T C Spelsberg, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 5, 2013
The non-interventional BonViva Intravenous Versus Alendronate (VIVA) study: real-world adherence and persistence to medication, efficacy, and safety, in patients with postmenopausal osteoporosisP Hadji, D Felsenberg, M Amling, et al.
Cell Death & Disease|February 26, 2016
p38 MAPK regulates the Wnt inhibitor Dickkopf-1 in osteotropic prostate cancer cellsA J Browne, A Göbel, S Thiele, et al.
The Journal of Clinical Endocrinology and Metabolism|May 14, 2011
Cortical bone status is associated with serum osteoprotegerin concentration in men: the STRAMBO studyP Szulc, G Hawa, S Boutroy, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1997
Soluble interleukin-1 receptor antagonist serum levels in smokers and nonsmokers with Graves' ophthalmopathy undergoing orbital radiotherapyL C Hofbauer, T Mühlberg, A König, et al.
Pageof 12